Clinical Case Reports (Apr 2021)

BRAF‐mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis

  • Francesca Abbati,
  • Annalisa Altimari,
  • Barbara Corti,
  • Emi Dika,
  • Francesca Sperandi,
  • Barbara Melotti

DOI
https://doi.org/10.1002/ccr3.3982
Journal volume & issue
Vol. 9, no. 4
pp. 2200 – 2204

Abstract

Read online

Abstract We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a BRAF/MEK inhibitor combination therapy (dabrafenib/trametinib), which was demonstrated to be effective and well‐tolerated.

Keywords